Can Whistleblowers Root Out Public Expenditure Fraud? Evidence from Medicare
Review of Economics and Statistics · 11.09.2025 · 107 (5) · 1169-1186
DOI: 10.1162/rest_a_01339 ↗Kurz gefasst
Fachartikel in der Zeitschrift Review of Economics and Statistics, online erschienen am 11.09.2025. Verfasst von Jetson Leder-Luis. Beteiligte Einrichtung: Boston University Questrom School of Business and NBER. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS.
Abstract (Originalsprache)
This paper analyzes private antifraud enforcement under the False Claims Act, which compensates whistleblowers for litigating against health care providers who overbill the US government. I conduct several case studies of successful whistleblower lawsuits concerning Medicare fraud, pairing new legal data with large samples of Medicare claims. I estimate that deterrence from $1.9 billion in whistleblower settlements generated Medicare cost savings of nearly $19 billion, while imposing low costs on the government. These results suggest private enforcement is a cost-effective way to combat public expenditure fraud.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Boston University Questrom School of Business and NBER.
Förderung
- NIA NIH HHS
Zitieren
APA
Leder-Luis, J. (2025). Can Whistleblowers Root Out Public Expenditure Fraud? Evidence from Medicare. Review of Economics and Statistics, 107(5), 1169-1186. https://doi.org/10.1162/rest_a_01339
Vancouver
Leder-Luis J. Can Whistleblowers Root Out Public Expenditure Fraud? Evidence from Medicare. Review of Economics and Statistics. 2025;107(5):1169-1186. doi:10.1162/rest_a_01339
BibTeX
@article{LederLuis2025,
author = {Leder-Luis, Jetson},
title = {Can Whistleblowers Root Out Public Expenditure Fraud? Evidence from Medicare},
journal = {Review of Economics and Statistics},
year = {2025},
volume = {107},
number = {5},
pages = {1169--1186},
doi = {10.1162/rest_a_01339}
}
EUVIMED